| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.097 | 0.05 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.06 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |